Association between hypertension, menopause, and cognition in women

Journal of Clinical Hypertension

Volumn 17, Issue 12, 2015, Pages 970-976

  Zilberman, Judith M ^a,b,c   Cerezo, Gustavo H ^b,d   Sueldo, Mildren Del ^e,f   Fernandez Pérez, Cristina ^g   Martell Claros, Nieves ^h   Vicario, Augusto ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO CARDIOVASCULAR DE BUENOS AIRES   (Argentina)

^c HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^d utico Central   (Argentina)

^e Programa Corazón Sano Municipalidad de Villa Maria   (Argentina)

^f Clínica de Especialidades   (Argentina)

^g Servicio de Medicina Preventiva   (Spain)

^h HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARGENTINA; BLOOD PRESSURE; COGNITION; COGNITIVE DYSFUNCTION; FEMALE; HUMAN; HYPERTENSION; MEMORY DISORDERS; MENOPAUSE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PSYCHOLOGY;

ADULT; ARGENTINA; BLOOD PRESSURE; COGNITION; COGNITIVE DYSFUNCTION; FEMALE; HUMANS; HYPERTENSION; MEMORY DISORDERS; MENOPAUSE; MIDDLE AGED; PREVALENCE;

EID: 85027919199     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12643     Document Type: Article

References (36)

1. Shaw LJ, Bugiardini R, Merz CNB. Women and Ischemic Heart Disease. J Am Coll Cardiol. 2009;54:1561–1575.
2. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension; analysis of worldwide data. Lancet. 2005;365:217– 223.
3. Hjortland MC, McNamara PM, Kannel WB. Some atherogenic concomitants of menopause: the Framingham Study. Am J Epidemiol. 1976;103:304–311.
4. Hernandez-Hernandez R, Silva H, Velasco M, et al; CARMELA Study Investigators. Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study. J Hypertens. 2010;28:24–34.
5. Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep. 2012;14:254–260.
6. Engberding N, Wenger NK. Management of hypertension in women. Hypertens Res. 2012;35:251–260.
7. Yaffe K, Vittinghoff E, Pletcher MJ, et al. Early adult to midlife cardiovascular risk factors and cognitive function. Circulation. 2014;129:1560–1567.
8. Mitchell SE, Woods FN. Midlife women’s attributions about perceived memory changes: observations from the Seattle Midlife Women’s Health Study. J Womens Health Gend Based Med. 2001;10:351–362.
9. Luine VN. Estradiol and cognitive function: past, present and future. Horm Behav. 2014;66:602–618.
10. Instituto Nacional de Estadisticas y Censos de la Republica Argentina (INDEC). Censo Nacional de poblaciones, hogares y viviendas 2010. http://www.indec.gov.ar. Accessed October 27, 2010.
11. Mancia G, De Backer G, Dominiczak A, et al; Authors/Task Force Members. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task force on the management of arterial hypertension. J Hypertens. 2007;25:1751–1762.
12. Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
13. Mosca L, Benjamın EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update a guideline from the American Heart Association. Circulation. 2011;123:1243–1262.
14. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/ American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004;109:433–438.
15. Alberti KG, Simmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553.
16. Vicario A, Cerezo GH, Zilberman J, et al. Guıa para la Evaluacion, de Trastornos Cognitivos en pacientes con Enfermedad Vascular. Segunda Edicion. Actualizacion 2013. Rev Arg Fed Cardiol 2013; 42: 1–96.
17. Allegri RF, Ollari JA, Mangone CA, et al. El “Mini Mental Statement Examination” en la Argentina: instrucciones para su administracion. Rev Neurol Arg. 1999;24:31–35.
18. Serrano CM, Allegri RF, Drake M, et al. A shortened form of the Spanish Boston naming test: a useful tool for the diagnosis of Alzheimer’s disease. Rev Neurol. 2001;33:624–627.
19. Wilkinson MJB, Barczak P. Psychiatric screening in general practice: comparison of the general health questionnaire and the hospital anxiety depression scale. J R Coll Gen Prac. 1988;38:311–313.
20. Wassertheil-Smoller S, Shumaker S, Ockene J, et al. Depression and cardiovascular sequelae in postmenopausal women. The Women’s Health Initiative (WHI). Arch Intern Med. 2004;164: 289–298.
21. Zanchetti A, Facchetti R, Cesana GC, et al; SIMONA participants. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens. 2005;23:2269–2276.
22. Nwankwo T, Yoon SS, Burt V, et al. Hypertension among adults in the United States: national health and nutrition examination survey, 2011-2012. NCHS Data Brief. 2013;133:1–8.
23. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (THE INTERHEART STUDY): case-control study. Lancet. 2004;364:937–952.
24. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129: 687–702.
25. Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001;32:2559–2566.
26. Duron E, Hanon O. Vascular Risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008;4:363–381.
27. De Carli C. Cerebrovascular disease: assessing the brain as an end-organ of vascular disease. Nat Rev Cardiol. 2012;9:435–436.
28. Gillies GE, McArthue S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev. 2010;62:155–198.
29. Mihalj M, Drenjancevic I, Vcev A, et al. Basic cognitive functions across the menstrual cycle in a controlled female cohort. Med Glas (Zenica). 2014;11:177–185.
30. Weber MT, Maki PM, McDermott MP. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2014;142:90–98.
31. Barton M, Meyer MR. Postmenopausal hypertension: mechanisms and therapy. Hypertension. 2009;54:11–18.
32. McBride SM, Flynn FW, Ren J. Cardiovascular alteration and treatment of hypertension. Do men and women differ? Endocrine. 2005;28:199–207.
33. Reckelhoff JF. Basic research into the mechanisms responsible for postmenopausal hypertension. Int J Clin Pract Suppl. 2004;139: 13–19.
34. Maranon R, Reckelhoff JF. Sex and gender differences in control of blood pressure. Clin Sci (Lond). 2013;125:311–318.
35. Cerezo GH, Vicario A, Vainstein N. Caracterısticas del sındrome metabolico en la consulta cardiologica. Grupo de estudio Carisma. Caracterizacion y Analisis del Riesgo en Individuos con Sındrome Metabolico en la Argentina). Rev Insuf Cardıaca. 2008;3: 11–15.
36. Martell-Claros N, Aranda P, Gonzalez-Albarran O, et al. Perception of health and understanding of cardiovascular risk among patients with recently diagnosed diabetes and/or metabolic syndrome. Eur J Prev Cardiol. 2013;20:21–28.